Style | Citing Format |
---|---|
MLA | Derakhshankhah H, et al.. "Immunoengineering Biomaterials in Cell-Based Therapy for Type 1 Diabetes." Tissue Engineering - Part B: Reviews, vol. 28, no. 5, 2022, pp. 1053-1066. |
APA | Derakhshankhah H, Sajadimajd S, Jahanshahi F, Samsonchi Z, Karimi H, Hajizadehsaffar E, Jafari S, Razmi M, Malvajerd SS, Bahrami G, Razavi M, Izadi Z (2022). Immunoengineering Biomaterials in Cell-Based Therapy for Type 1 Diabetes. Tissue Engineering - Part B: Reviews, 28(5), 1053-1066. |
Chicago | Derakhshankhah H, Sajadimajd S, Jahanshahi F, Samsonchi Z, Karimi H, Hajizadehsaffar E, Jafari S, et al.. "Immunoengineering Biomaterials in Cell-Based Therapy for Type 1 Diabetes." Tissue Engineering - Part B: Reviews 28, no. 5 (2022): 1053-1066. |
Harvard | Derakhshankhah H et al. (2022) 'Immunoengineering Biomaterials in Cell-Based Therapy for Type 1 Diabetes', Tissue Engineering - Part B: Reviews, 28(5), pp. 1053-1066. |
Vancouver | Derakhshankhah H, Sajadimajd S, Jahanshahi F, Samsonchi Z, Karimi H, Hajizadehsaffar E, et al.. Immunoengineering Biomaterials in Cell-Based Therapy for Type 1 Diabetes. Tissue Engineering - Part B: Reviews. 2022;28(5):1053-1066. |
BibTex | @article{ author = {Derakhshankhah H and Sajadimajd S and Jahanshahi F and Samsonchi Z and Karimi H and Hajizadehsaffar E and Jafari S and Razmi M and Malvajerd SS and Bahrami G and Razavi M and Izadi Z}, title = {Immunoengineering Biomaterials in Cell-Based Therapy for Type 1 Diabetes}, journal = {Tissue Engineering - Part B: Reviews}, volume = {28}, number = {5}, pages = {1053-1066}, year = {2022} } |
RIS | TY - JOUR AU - Derakhshankhah H AU - Sajadimajd S AU - Jahanshahi F AU - Samsonchi Z AU - Karimi H AU - Hajizadehsaffar E AU - Jafari S AU - Razmi M AU - Malvajerd SS AU - Bahrami G AU - Razavi M AU - Izadi Z TI - Immunoengineering Biomaterials in Cell-Based Therapy for Type 1 Diabetes JO - Tissue Engineering - Part B: Reviews VL - 28 IS - 5 SP - 1053 EP - 1066 PY - 2022 ER - |